Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OPKO HEALTH, INC.OPK · Entity 4891 | Director | June 24, 2021 | June 25, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OPKO HEALTH, INC.
Report date June 24, 2021 · Filed June 25, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.77 · Expires 2031-06-23 | Direct | 30,000 |
Reported balance
After 2021-06-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-24 · Grant · Acquired 30,000 · Balance 30,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2021 Filed Jun 25, 2021 12:43 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.77 | $0.00 |
DisclosureSEC source: 0001209191-21-043211 · doc4.xml · derivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-06-23 Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 21:07 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001209191-21-005357 · doc4.xml · derivative · entry 5 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2029-06-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 21:07 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | Exercise / conversionStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $3.04 | $0.00 |
DisclosureSEC source: 0001209191-21-005357 · doc4.xml · derivative · entry 4 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2028-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 21:07 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | Exercise / conversionCommon Stock | 20,000 | $2.03 | $40,600.00 |
DisclosureSEC source: 0001209191-21-005357 · doc4.xml · nonDerivative · entry 2 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 21:07 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | Exercise / conversionCommon Stock | 40,000 | $3.04 | $121,600.00 |
DisclosureSEC source: 0001209191-21-005357 · doc4.xml · nonDerivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2020 Filed Jun 26, 2020 12:46 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001209191-20-039037 · doc4.xml · derivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-06-24 Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 10:38 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001209191-19-038351 · doc4.xml · derivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-06-19 Read SEC document |
| May 28, 2019 Filed May 29, 2019 10:10 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 50,000 | $1.92 | $96,000.00 |
DisclosureSEC source: 0001209191-19-033120 · doc4.xml · nonDerivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,120,728 F1 · ownership.nature: These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation. Read SEC document |
| September 07, 2018 Filed Sep 10, 2018 10:30 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 10,000 | $4.63 | $46,300.00 |
DisclosureSEC source: 0001209191-18-050181 · doc4.xml · nonDerivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,070,728 F1 · ownership.nature: These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation. Read SEC document |
| July 11, 2018 Filed Jul 12, 2018 11:12 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 2,500 | $6.00 | $14,991.25 |
DisclosureSEC source: 0001209191-18-042414 · doc4.xml · nonDerivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,060,728 F1 · ownership.nature: These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation. Read SEC document |
| June 21, 2018 Filed Jun 22, 2018 20:14 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001209191-18-039174 · doc4.xml · derivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-06-20 Read SEC document |
| May 29, 2018 Filed May 30, 2018 11:29 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 2,500 | $3.73 | $9,332.50 |
DisclosureSEC source: 0001209191-18-034061 · doc4.xml · nonDerivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,058,228 F1 · ownership.nature: These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation. Read SEC document |
| May 14, 2018 Filed May 15, 2018 10:04 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 1,800 | $4.79 | $8,622.00 |
DisclosureSEC source: 0001209191-18-030093 · doc4.xml · nonDerivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ALSAR Ltd. Partnership Disclosed balance after: 4,055,728 F1 · ownership.nature: These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation. Read SEC document |
| May 04, 2018 Filed May 7, 2018 10:57 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 5,000 | $3.14 | $15,700.00 |
DisclosureSEC source: 0001209191-18-028209 · doc4.xml · nonDerivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,053,928 Read SEC document |
| April 25, 2018 Filed Apr 26, 2018 10:24 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 2,500 | $3.03 | $7,575.00 |
DisclosureSEC source: 0001209191-18-026150 · doc4.xml · nonDerivative · entry 3 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,048,928 F1 · ownership.nature: These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation. Read SEC document |
| April 25, 2018 Filed Apr 26, 2018 10:24 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 5,000 | $2.97 | $14,850.00 |
DisclosureSEC source: 0001209191-18-026150 · doc4.xml · nonDerivative · entry 2 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,046,428 F1 · ownership.nature: These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation. Read SEC document |
| April 25, 2018 Filed Apr 26, 2018 10:24 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 5,000 | $2.94 | $14,700.00 |
DisclosureSEC source: 0001209191-18-026150 · doc4.xml · nonDerivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,041,428 F1 · ownership.nature: These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation. Read SEC document |
| April 16, 2018 Filed Apr 17, 2018 10:52 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 10,000 | $3.01 | $30,100.00 |
DisclosureSEC source: 0001209191-18-025059 · doc4.xml · nonDerivative · entry 2 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,036,428 F1 · ownership.nature: These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation. Read SEC document |
| April 16, 2018 Filed Apr 17, 2018 10:52 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 5,000 | $3.00 | $15,000.00 |
DisclosureSEC source: 0001209191-18-025059 · doc4.xml · nonDerivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,026,428 F1 · ownership.nature: These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation. Read SEC document |
| April 13, 2018 Filed Apr 16, 2018 10:48 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 10,000 | $3.02 | $30,200.00 |
DisclosureSEC source: 0001209191-18-024884 · doc4.xml · nonDerivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,021,428 F1 · ownership.nature: These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation. Read SEC document |
| April 06, 2018 Filed Apr 9, 2018 10:07 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 10,000 | $3.16 | $31,600.00 |
DisclosureSEC source: 0001209191-18-024269 · doc4.xml · nonDerivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,011,428 F1 · ownership.nature: These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation. Read SEC document |
| April 03, 2018 Filed Apr 4, 2018 20:13 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $3.04 | $0.00 |
DisclosureSEC source: 0001209191-18-023608 · doc4.xml · derivative · entry 1 Fishel Robert Scott · CIK 0001735476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-04-02 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.